Overview

Dose Ranging Study With LT, Monotherapy, PPAR

Status:
Completed

Trial end date:
2006-06-01

Target enrollment:

Participant gender:

Summary

A Randomized, Double-Blind, Dose-Ranging, Dose Comparison-Controlled Trial to Determine the Safety and Efficacy of BMS-298585 in Subjects with Type 2 Diabetes

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Bristol-Myers Squibb